دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Catheter-Induced Postextrasystolic Potentiation in the Assessment of Severity of Low-Gradient Aortic Valve Stenosis.
Dehghani, Payam MD; Singh, Jyotpal PhD; Singer, Zachary MD; Booker, Jeffrey MD; Lavoie, Andrea J. MD; Zimmermann, Rodney H. MD; Shavadia, Jay S. MD; Webb, John G. MD; Clavel, Marie-Annick DVM, PhD; Pibarot, Philippe DVM, PhD
doi : 10.1161/CIRCINTERVENTIONS.123.012892
Volume 16(5) pgs. e012892-e013021 May 2023
Deciphering which patients with low-gradient aortic valve disease have severe stenosis can be difficult. We aimed to correlate the postextrasystolic potentiation (PESP) with dobutamine stress echocardiography and multidetector computed tomography in patients with low-gradient aortic valve stenosis.
Clinical Presentation and Medium-Term Outcomes of Children With Anomalous Aortic Origin of the Left Coronary Artery: High-Risk Features Beyond Interarterial Course.
Doan, Tam T. MD, MSc ,*; Wilkes, J. Kevin MD ,*; Reaves O'Neal, Dana L. APRN, CPNP-PC/AC; Bonilla-Ramirez, Carlos MD; Sachdeva, Shagun MD; Masand, Prakash MD; Mery, Carlos M. MD, MPH; Binsalamah, Ziyad MD; Heinle, Jeffrey S. MD; Molossi, Silvana MD, PhD
doi : 10.1161/CIRCINTERVENTIONS.122.012635
Anomalous aortic origin of the left coronary artery (AAOLCA) confers a rare, but significant, risk of sudden cardiac death in children. Surgery is recommended for interarterial AAOLCA, and other subtypes considered benign.
Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention.
Yamamoto, Ko MD; Shiomi, Hiroki MD; Morimoto, Takeshi MD, MPH; Miyazawa, Akiyoshi MD; Watanabe, Hiroki MD; Natsuaki, Masahiro MD; Watanabe, Hirotoshi MD; Yamaji, Kyohei MD; Ohya, Masanobu MD; Nakamura, Sunao MD; Mitomo, Satoru MD; Suwa, Satoru MD; Domei, Takenori MD; Tatsushima, Shojiro MD; Ono, Koh MD; Sakamoto, Hiroki MD; Shimamura, Kiyotaka MD; Shigetoshi, Masataka MD; Taniguchi, Ryoji MD; Nishimoto, Yuji MD; Okayama, Hideki MD; Matsuda, Kensho MD; Yokomatsu, Takafumi MD; Muto, Masahiro MD; Kawaguchi, Ren MD; Kishi, Koichi MD; Hadase, Mitsuyoshi MD; Fujita, Tsutomu MD; Nishida, Yasunori MD; Nishino, Masami MD; Otake, Hiromasa MD; Suematsu, Nobuhiro MD; Ajimi, Tsuneki MD; Tanabe, Kengo MD; Abe, Mitsuru MD; Hibi, Kiyoshi MD; Kadota, Kazushige MD; Ando, Kenji MD; Kimura, Takeshi MD; On behalf of the OPTIVUS-Complex PCI Investigators
doi : 10.1161/CIRCINTERVENTIONS.123.012922
Several stent expansion criteria derived from the intravascular ultrasound (IVUS) evaluation have been proposed to predict future clinical outcomes, but optimal stent expansion criteria as a guide during percutaneous coronary intervention (PCI) are still controversial.
Transcatheter Aortic Valve Replacement in Patients With Reduced Ejection Fraction and Nonsevere Aortic Stenosis.
Ludwig, Sebastian MD ,,,*; Schofer, Niklas MD ,,,*; Abdel-Wahab, Mohamed MD; Urena, Marina MD; Jean, Guillaume MD; Renker, Matthias MD; Hamm, Christian W. MD; Thiele, Holger MD; Iung, Bernard MD; Ooms, Joris F. MD; Wiessman, Maya MD; Mogensen, Nils S.B. MD; Longere, Benjamin MD; Perrin, Nils MD; Ben Ali, Walid MD, PhD; Coisne, Augustin MD, PhD; Dahl, Jordi S. MD, PhD; Van Mieghem, Nicolas M. MD; Kornowski, Ran MD; Kim, Won-Keun MD; Clavel, Marie-Annick DVM, PhD
doi : 10.1161/CIRCINTERVENTIONS.122.012768
The potential benefit of transcatheter aortic valve replacement (TAVR) in patients with nonsevere aortic stenosis (AS) and heart failure is controversial.
Looking at Aortic Valve Disease Through the Lens of Preservation of At-Risk Myocardium.
Tully, Andy MD; Norton, Elizabeth L. MD; Deas, Dale S. MD; Kalra, Kanika MD; Grubb, Kendra J. MD, MHA
Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes.
Waksman, Ron MD; Bhogal, Sukhdeep MD; Gordon, Paul MD; Ehsan, Afshin MD; Wilson, Sean R. MD; Levitt, Robert MD; Parikh, Puja MD; Bilfinger, Thomas MD, ScD; Hanna, Nicholas MD; Buchbinder, Maurice MD; Asch, Federico M. MD; Kim, Francis Y. MD; Weissman, Gaby MD; Ben-Dor, Itsik MD; Shults, Christian C. MD; Ali, Syed MBBS; Sutton, Joseph A. BS; Shea, Corey MS; Zhang, Cheng PhD; Garcia-Garcia, Hector M. MD, PhD; Satler, Lowell F. MD; Rogers, Toby MD, PhD
doi : 10.1161/CIRCINTERVENTIONS.122.012655
The LRT trial (Low-Risk Transcatheter Aortic Valve Replacement [TAVR]) demonstrated the safety and feasibility of TAVR in low-risk patients, with excellent 1- and 2-year outcomes.
Subclinical Thrombosis on Valve Durability in Low-Risk Transcatheter Aortic Valve Replacement Patients: Mid-Term Data Reassuring, but Longer Follow-Up Needed.
Khera, Sahil MD, MPH; Tang, Gilbert H.L. MD, MSc, MBA
Correlation Between Fontan Pathway Diameter and Inferior-Superior Vena Cava Gradients in Adults Undergoing Exercise Catheterization.
Miranda, William R. MD; Jain, C. Charles MD; Burchill, Luke J. MBBS, PhD; Cabalka, Allison K. MD; Hagler, Donald J. MD; Francois, Christopher J. MD; Connolly, Heidi M. MD; Egbe, Alexander C. MBBS
Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives.
Mesnier, Jules MD ,*; Cepas-Guillen, Pedro MD, PhD ,*; Freixa, Xavier MD, PhD; Flores-Umanzor, Eduardo MD, PhD; Hoang Trinh, Kim MSc; O'Hara, Gilles MD; Rodes-Cabau, Josep MD, PhD
doi : 10.1161/CIRCINTERVENTIONS.122.012812
AB Left atrial appendage closure is an alternative to chronic oral anticoagulation to prevent embolic events related to nonvalvular atrial fibrillation. After device implantation, antithrombotic treatment is prescribed to prevent device-related thrombosis, a dreadful complication associated with an increased risk of ischemic events.
Letter by Piriou et al Regarding Article, "Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation".
Piriou, Pierre-Guillaume MD; Plessis, Julien MD; Guerin, Patrice MD, PhD
Response to Letter by Piriou et al Regarding Article, "Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation".
Costa, Giuliano MD; Tamburino, Corrado MD, PhD; Barbanti, Marco MD
